India is the world’s largest vaccine manufacturer. However, in order to meet domestic demands, it had temporarily halted exports in April. Now, New Delhi is set to resume export of the vaccines under the ‘Vaccine Maitri’ programme from October to fulfill its commitment towards COVAX, Union Health Minister Mansukh Mandaviya had said on Monday.
The Drugs Controller General of India had last month given emergency use authorisation to the J&J vaccine, imported or locally supplied by the company’s Indian partner Biological E.
However, the central government is yet to sign a supply deal with J&J.
“J&J doses are expected from next month. Bio E will do the formulation and make 5 ml vials,” the source said.
A J&J India spokesperson said “it was premature for us to speculate on the timing of our vaccine deliveries”.
News Source: Johnson & Johnson
